GLP-1 persistence: What semaglutide data reveals about patient behavior
As the new year begins, many patients refocus on weight management and long-term health goals. At...
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL). While PPRL remains essential for de-identified data exchange, the study presented during our recent webinar shows that certain token-based approaches...
As the new year begins, many patients refocus on weight management and long-term health goals. At...
Artificial intelligence is no longer something healthcare and life sciences teams are testing on...
Regulatory decision-making depends on evidence that reflects how medical products perform in...
Industry trends in ulcerative colitis research: a new path Ulcerative colitis is a chronic...
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL)....
Early signals indicate continued declines in influenza vaccination uptake and shifts in the...
Our team had a great time at HCIC connecting with healthcare marketers, digital teams and consumer...
Real-world evidence (RWE) studies often stall on the same friction points: defining the most...
Veterans Day invites us to look beyond branch and rank to the people and stories behind the...
Alzheimer’s disease burden and the current therapy pipeline Alzheimer’s disease remains the leading...
As the new year begins, many patients refocus on weight management and long-term health goals. At the same time, GLP-1 drugs have reshaped the obesity treatment landscape.1,2 With semaglutide and other GLP-1 medications in high demand for weight loss...